Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VOWST™ safely and effectively. See full prescribing information for VOWST. VOWST (fecal microbiota spores, live-brpk) capsules, for oral administration Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI). Limitation of Use: VOWST is not indicated for treatment of CDI.
- generic_name
- fecal microbiota spores, live-brpk
- product_names
- fecal microbiota spores, live-brpk
- ndc
- 71881-400, 71881-400-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en